Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evaluating the process-reactive dimension.

W G Herron

    Schizophrenia Bulletin
    |January 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    The process-reactive dimension effectively predicted short-term outcomes in older schizophrenia diagnoses (DSM-II) but not in newer ones (DSM-III). This suggests its value may lie in the broader schizophrenia spectrum, not just schizophrenia itself.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A comparison of dose-response curves in cognitive-behavioral and psychodynamic psychotherapies.

    Journal of clinical psychology·2001
    Same author

    Severity of symptoms of depression and anxiety as predictors of duration of psychotherapy.

    Psychological reports·1998
    Same author

    Methodological problems encountered in research with psychiatric inpatients: a case example.

    Bulletin of the Menninger Clinic·1997
    Same author

    Interpersonal perceptions of depressed and borderline inpatients.

    Journal of clinical psychology·1997
    Same author

    Ethnic diversification in clinical psychology graduate training.

    Cultural diversity and mental health·1997
    Same author

    The psychogenesis of poverty: some psychoanalytic conceptions.

    Psychoanalytic review·1996
    Same journal

    Reconsidering the Term "Treatment Resistant Schizophrenia".

    Schizophrenia bulletin·2026
    Same journal

    The Effect of Semaglutide on Antipsychotic-Induced Weight Gain and Other Metabolic Parameters, among a Cohort of Inpatients.

    Schizophrenia bulletin·2026
    Same journal

    Comparing Apples to Oranges Obscures Tortoises Beating Hares: The Relationship Between Rate of Antipsychotic Tapering and Relapse.

    Schizophrenia bulletin·2026
    Same journal

    Beyond the Need for Speed: D2 Receptor Affinity Predicts Relapse after Antipsychotic Tapering in First Episode Psychosis.

    Schizophrenia bulletin·2026
    Same journal

    Correction to: The Mini-CAARMS: Development and Validation of a Short Version of the Comprehensive Assessment of AT Risk Mental States to Facilitate Preventive Psychiatry.

    Schizophrenia bulletin·2026
    Same journal

    Longitudinal Impact of Birthweight and its Polygenic Risk Score on Glucose and Antipsychotic-Induced Weight Gain in First Episode Psychosis.

    Schizophrenia bulletin·2026
    See all related articles

    Area of Science:

    • Psychiatry
    • Clinical Psychology
    • Psychopathology

    Background:

    • The process-reactive dimension has been used to predict schizophrenia outcomes.
    • Previous research indicated limitations in its long-term predictive power for early-phase DSM-III schizophrenics.
    • Diagnostic criteria changes may impact the utility of established predictive models.

    Purpose of the Study:

    • To evaluate the process-reactive dimension's utility as a short-term outcome predictor in DSM-II versus DSM-III schizophrenia.
    • To explore the impact of diagnostic shifts on the effectiveness of the process-reactive dimension.
    • To reconsider the application of the process-reactive dimension within the schizophrenia spectrum.

    Main Methods:

    • Comparison of two studies examining the process-reactive dimension's predictive success.

    Related Experiment Videos

  • Analysis of short-term outcome prediction in DSM-II schizophrenia cohorts.
  • Analysis of short-term outcome prediction in DSM-III schizophrenia cohorts.

    • Main Results:

    • The process-reactive dimension showed good success as a short-term predictor for DSM-II schizophrenia.
    • The process-reactive dimension demonstrated poor success as a short-term predictor for DSM-III schizophrenia.
    • Changes in diagnostic criteria (DSM-II to DSM-III) appear to have reduced schizophrenia heterogeneity.

    Conclusions:

    • The process-reactive dimension may be more relevant for a schizophrenia spectrum than for narrowly defined schizophrenia.
    • Re-evaluation of schizophrenia heterogeneity is needed to ascertain the process-reactive dimension's utility.
    • Diagnostic evolution necessitates reassessment of established predictive frameworks in psychiatric research.